| Frontal–subcortical neuronal circuits and clinical neuropsychiatry: an update S Tekin, JL Cummings Journal of psychosomatic research 53 (2), 647-654, 2002 | 1737 | 2002 |
| Rivastigmine for dementia associated with Parkinson's disease M Emre, D Aarsland, A Albanese, EJ Byrne, G Deuschl, PP De Deyn, ... New England Journal of Medicine 351 (24), 2509-2518, 2004 | 1629 | 2004 |
| Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress D Aarsland, K Brønnick, U Ehrt, PP De Deyn, S Tekin, M Emre, ... Journal of Neurology, Neurosurgery & Psychiatry 78 (1), 36-42, 2007 | 716 | 2007 |
| Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study HH Feldman, S Ferris, B Winblad, N Sfikas, L Mancione, Y He, S Tekin, ... The Lancet Neurology 6 (6), 501-512, 2007 | 457 | 2007 |
| Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease S Tekin, MS Mega, DM Masterman, T Chow, J Garakian, HV Vinters, ... Annals of neurology 49 (3), 355-361, 2001 | 399 | 2001 |
| Behavioral symptoms in mild cognitive impairment H Feldman, P Scheltens, E Scarpini, N Hermann, P Mesenbrink, ... Neurology 62 (7), 1199-1201, 2004 | 345 | 2004 |
| Impact of APOE in mild cognitive impairment MR Farlow, Y He, S Tekin, J Xu, R Lane, HC Charles Neurology 63 (10), 1898-1901, 2004 | 290 | 2004 |
| Attentional deficits affect activities of daily living in dementia associated with Parkinson's Disease K Bronnick, M Emre, PP De Deyn, S Tekin, D Aarsland Parkinsonism & Related Disorders 12, 29, 2006 | 224 | 2006 |
| Neuropathologic correlates of apathy in Alzheimer’s disease GA Marshall, LA Fairbanks, S Tekin, HV Vinters, JL Cummings Dementia and geriatric cognitive disorders 21 (3), 144-147, 2006 | 178 | 2006 |
| Activities of daily living in Alzheimer's disease: neuropsychiatric, cognitive, and medical illness influences S Tekin, LA Fairbanks, S O'Connor, S Rosenberg, JL Cummings The American Journal of Geriatric Psychiatry 9 (1), 81-86, 2001 | 176 | 2001 |
| Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study W Poewe, E Wolters, M Emre, M Onofrj, C Hsu, S Tekin, R Lane Movement disorders: official journal of the Movement Disorder Society 21 (4 …, 2006 | 158 | 2006 |
| Early-onset Alzheimer’s disease is associated with greater pathologic burden GA Marshall, LA Fairbanks, S Tekin, HV Vinters, JL Cummings Journal of geriatric psychiatry and neurology 20 (1), 29-33, 2007 | 154 | 2007 |
| Profile of cognitive impairment in dementia associated with Parkinson’s disease compared with Alzheimer’s disease K Bronnick, M Emre, R Lane, S Tekin, D Aarsland Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1064-1068, 2007 | 135 | 2007 |
| Antiglutamatergic therapy in Alzheimer's disease–effects of lamotrigine S Tekin, C Aykut-Bingöl, T Tanrıdağ, S Aktan Journal of Neural Transmission 105, 295-303, 1998 | 87 | 1998 |
| Neuropathologic correlates of activities of daily living in Alzheimer disease GA Marshall, LA Fairbanks, S Tekin, HV Vinters, JL Cummings Alzheimer Disease & Associated Disorders 20 (1), 56-59, 2006 | 75 | 2006 |
| Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson’s disease dementia: a retrospective analysis of a double-blind trial and an open-label … W Oertel, W Poewe, E Wolters, PP De Deyn, M Emre, C Kirsch, C Hsu, ... Drug safety 31, 79-94, 2008 | 56 | 2008 |
| Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension G Grossberg, C Sadowsky, H Förstl, L Frölich, J Nagel, S Tekin, ... Alzheimer Disease & Associated Disorders 23 (2), 158-164, 2009 | 54 | 2009 |
| Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias C Ballard, R Lane, P Barone, R Ferrara, S Tekin International journal of clinical practice 60 (6), 639-645, 2006 | 48 | 2006 |
| Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia FA Schmitt, MR Farlow, X Meng, S Tekin, JT Olin CNS neuroscience & therapeutics 16 (6), 330-336, 2010 | 47 | 2010 |
| Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer’s disease JL Cummings, MR Farlow, X Meng, S Tekin, JT Olin Clinical drug investigation 30, 41-49, 2010 | 47 | 2010 |
